Form 4: Cidara Therapeutics Executive Sells Shares to Cover Tax Obligations

Leslie Tari, Chief Scientific Officer of Cidara Therapeutics, sold shares to cover tax withholding obligations related to the vesting and settlement of RSUs.

Summary

• On March 11, 2024, Leslie Tari, the Chief Scientific Officer of Cidara Therapeutics, sold 21,029 shares of common stock at a weighted average price of $0.6698.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
• Following the transaction, Tari directly owns 258,681 shares of Cidara Therapeutics common stock and indirectly owns 1,484 shares through a spouse.
• Tari also acquired 4,000 shares through the Employee Stock Purchase Plan (ESPP) on November 20, 2023.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain information that would significantly impact sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and are generally not indicative of the company's performance or future prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates